Filing Flows › Medpace Holdings (MEDP) › Q2 2026
Medpace Holdings (MEDP) Q2 2026 earnings results (second quarter 2026)
10-Q filed Jul 23, 2026
Medpace Holdings (MEDP) reported revenue of $707M for the second quarter 2026 (Q2 2026), +17% from a year earlier and +0.1% from the quarter before. Operating margin was 20.8%, net earnings $121M (17.2% of revenue).
Medpace Holdings, Q2 2026: revenue $707M (+17% year over year), operating margin 20.8%, net earnings $121M, operating cash flow $162M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $707M | +0.1% | +17% |
| Operating profit | $147M | +4% | +16% |
| Net earnings | $121M | -2% | +34% |
| Operating cash flow | $162M | +7% | +9% |
| Free cash flow | $138M | -5% | -3% |
What changed
Revenue was $707.3M in Q2 2026, up 17% year over year and roughly flat from the previous quarter. Other was the largest line at 31% of revenue. Other added $71.2M year over year (up 48%), 68% of the total change. Oncology declined 17%.
Operating profit was $146.8M, a 20.8% margin (down 0.2 points year over year). Of the extra revenue versus Q2 2025, 20% reached operating profit, below the 21% margin then. Total costs grew 18% against revenue growth of 17%. The fastest-growing cost line was Other operating costs (+19%). Net earnings were $121.4M, up 34% year over year. The effective tax rate was 20.0%.
Operating cash flow was $162.0M (up 9% year over year), 133% of net earnings. Non-cash charges added back $6.7M of depreciation and amortization and $4.3M of share-based compensation. Working capital and other items added $29.6M. Capital expenditures of $23.9M left free cash flow of $138.1M.
Questions
What was Medpace Holdings' revenue in the second quarter 2026?
Medpace Holdings (MEDP) reported revenue of $707M for the second quarter 2026 (Q2 2026), +17% from a year earlier and +0.1% from the quarter before.
Was Medpace Holdings profitable in the second quarter 2026?
Operating profit was $147M (20.8% of revenue) and net earnings $121M.
Source: Medpace Holdings 10-Q on SEC EDGAR.